STLN (NASDAQ: STLN) net income
STLN reported a net loss of $60.6m for fiscal 2025; in fiscal 2024 it reported a net loss of $64.7m. Earnings per share were −$0.54.
STLN's best year of the last 6 was fiscal 2022. It reported a loss in 5 of those 6 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$60.6m | — | −12.1% | −$0.54 |
| 2024 | −$64.7m | — | −16.4% | −$0.71 |
| 2023 | −$83.1m | −54,750.0% | −25.6% | −$0.92 |
| 2022 | $0.2m | — | 0.1% | $0.00 |
| 2021 | −$10.9m | — | −5.4% | −$0.16 |
| 2020 | −$14.3m | — | −7.6% | −$0.24 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
STLN net income compared with its sector
By net income for its latest fiscal year, STLN ranks 278th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of STLN, −12.1%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 276th | Contineum Therapeutics | −$60.0m | — |
| 277th | Fulgent Genetics | −$60.5m | −18.8% |
| 278th | STLN | −$60.6m | −12.1% |
| 279th | Ardelyx | −$61.6m | −15.1% |
| 280th | Alto Neuroscience | −$63.2m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of STLN
- How much did STLN earn in fiscal 2025?
- STLN reported a net loss of $60.6m for fiscal 2025. In fiscal 2024 it reported a net loss of $64.7m.
- What are the earnings per share of STLN?
- They were −$0.54 in fiscal 2025, compared with −$0.71 in fiscal 2024.
- What was the most profitable year for STLN?
- Of its last 6 fiscal years, fiscal 2022, with $0.2m.
- Where does STLN rank in its sector by net income?
- It ranks 278th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for STLN come from?
- From the annual report (Form 10-K) that STLN files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that STLN files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on STLN: the STLN page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.